Research areas : hematologic malignancies and hematologic immune diseases; construction of CAR-T clinical research system.
Cutting-edge technology: creation of translational medicine wards and CAR-T clinical trial screening system.
Specializes in treating: acute myeloid leukemia, multiple myeloma, and lymphoma.
Academic Highlights: Led the establishment of China's first translational medicine ward in hematology; emphasized that CAR-T "is a novel immunotherapy that acts on the tumor microenvironment and has revolutionary significance."